**Core Concept**
Paclitaxel, a chemotherapeutic agent, stabilizes microtubules by binding to tubulin, thereby inhibiting cell division and inducing apoptosis in rapidly dividing cancer cells. This mechanism is crucial for its antineoplastic effects.

**Why the Correct Answer is Right**
Paclitaxel works by binding to the beta subunit of tubulin and preventing the disassembly of microtubules. This leads to the formation of stable microtubule bundles, which interfere with the normal function of the mitotic spindle, ultimately resulting in cell cycle arrest at the G2/M phase. The stabilization of microtubules also prevents the normal breakdown and reformation of the microtubule network, which is essential for cell division.

**Why Each Wrong Option is Incorrect**
* **Option A:** This is not a known mechanism of action for paclitaxel. While paclitaxel does affect cell cycle progression, it does so by stabilizing microtubules, not by inhibiting topoisomerase.
* **Option B:** Paclitaxel does not work by inducing DNA damage or interfering with DNA replication. Its mechanism of action is distinct from that of alkylating agents or DNA intercalating agents.
* **Option D:** Paclitaxel does not act by inhibiting microsomal enzymes or affecting the cytochrome P450 system. Its mechanism of action is specific to the stabilization of microtubules.

**Clinical Pearl / High-Yield Fact**
Paclitaxel is often used in combination with other chemotherapeutic agents, such as carboplatin, to enhance its antitumor effects. The combination of paclitaxel and carboplatin is commonly used in the treatment of ovarian, breast, and lung cancers.

**Correct Answer: C. Stabilization of microtubules.**